Oncolytics Biotech Files 6-K
Ticker: ONCY · Form: 6-K · Filed: Apr 24, 2025 · CIK: 1129928
Sentiment: neutral
Topics: regulatory-filing, foreign-private-issuer, 6-K
TL;DR
ONCOLYTICS BIOTECH (ONCY) filed a 6-K, confirming 20-F annual report filing. Standard update.
AI Summary
Oncolytics Biotech Inc. filed a Form 6-K on April 24, 2025, reporting as a foreign private issuer. The filing indicates the company is based in Calgary, Alberta, Canada, and operates in the Pharmaceutical Preparations sector. It confirms the company will file its annual reports under Form 20-F.
Why It Matters
This filing provides routine updates for investors and regulatory bodies regarding Oncolytics Biotech Inc.'s status as a foreign private issuer and its reporting obligations.
Risk Assessment
Risk Level: low — This is a routine administrative filing (6-K) and does not contain new material financial or operational information that would typically increase risk.
Key Players & Entities
- ONCOLYTICS BIOTECH INC (company) — Filer of the 6-K report
- Calgary, Alberta, Canada (location) — Company's principal executive offices
- 2834 (industry_code) — Standard Industrial Classification for Pharmaceutical Preparations
- 001-38512 (company_id) — SEC File Number for Oncolytics Biotech Inc.
FAQ
What is the purpose of a Form 6-K filing?
A Form 6-K is a report of foreign private issuers required to be filed with the SEC to provide information that the company has made or is required to make public pursuant to the laws of its home country, or that it has filed or will file with a stock exchange on which its securities are traded.
What type of company is Oncolytics Biotech Inc. according to this filing?
Oncolytics Biotech Inc. is identified as a foreign private issuer.
Which annual report form will Oncolytics Biotech Inc. file?
Oncolytics Biotech Inc. will file its annual reports under cover of Form 20-F.
Where are Oncolytics Biotech Inc.'s principal executive offices located?
The principal executive offices of Oncolytics Biotech Inc. are located at Suite 804, 322 11th Avenue SW, Calgary, Alberta, Canada T2R 0C5.
What is the Standard Industrial Classification code for Oncolytics Biotech Inc.?
The Standard Industrial Classification code for Oncolytics Biotech Inc. is 2834, which corresponds to Pharmaceutical Preparations.
Filing Details
This Form 6-K (Form 6-K) was filed with the SEC on April 24, 2025 regarding ONCOLYTICS BIOTECH INC (ONCY).